Atlas Trials

The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.

Clinical trial NCT02625103 · COMPLETED

Trial details

NCT number
NCT02625103
Sponsor
Anders Fink-Jensen, MD, DMSci
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2015-09-01
Primary completion
2015-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.